AI in Healthcare and Life Sciences Podcast
The AI in Healthcare and Life Sciences Podcast is for non-technical leaders interested in where AI is creating an impact for patients, business workflows, and the bottom line. Global Fortune 500 healthcare and life sciences leaders join the Emerj AI Research team and CEO Daniel Faggella to share where they're seeing AI impact today, as well as best-practices for AI adoption and ROI measurement in healthcare and pharma.
Episodes
AI and Customer Experience in Behavioral Health - with Dwayne Stevens of WestCare
Administrative documentation is consuming thousands of clinician hours a year in behavioral health, pushing burnout higher and pulling staff away from direct patient care. In this episode, Dwayne Stevens, Chief Information Officer at Westcare Foundation, examines how AI-assisted documentation built into his organization's internally developed electronic health record is returning time to clinicia
What Service Leaders Get Wrong When Building the AI Business Case - with Ryan Makely of Bruker
Field service leaders in medical devices are under pressure to translate operational wins like first-time fix rates into hard financial outcomes their CFOs will fund. In this episode, Ryan Makely, Senior Director, CALID Service at Bruker, examines why conventional service metrics often fail to connect to profit and loss, and how leaders can build a financial case for AI-driven service investment.
How AI Is Closing the Knowledge Gap in MedTech Field Service - with Mohit Sheera of Terumo Blood and Cell Technologies
Field service leaders in MedTech are facing a widening gap between rising equipment complexity and the technician expertise, data, and parts logistics needed to keep devices running. In this episode, Mohit Sheera, Strategic Planning Leader at Terumo Blood and Cell Technologies, examines how AI-enabled remote diagnostics and multimodal data synthesis are changing who can resolve a service issue and
Closing the Decision‑Making Gap in Healthcare AI - with Raman Kaur of Elsevier
Fragmented data environments continue to slow clinical and operational decision‑making, even as AI adoption accelerates across healthcare. In this episode, Raman Kaur, Vice President of Technology at Elsevier, examines how leaders can close the gap between information and action with host Yolandi De Weerdt, focusing on context, shared definitions, and workflow‑aligned AI. She highlights the practi
Rethink Healthcare Workforce Strain with Data Enablement - with Tony Pastorino of Resultant
Clinician burnout takes hold long before most healthcare leaders see it, and the signals that could forecast it are often already being collected, but locked inside systems and teams that don't communicate. In this episode, Tony Pastorino, Director of Healthcare Strategy at Resultant, examines how a shift from data governance to what he calls "data enablement", paired with predictive analytics and
Driving the Transformation of Drug Discovery Through AI‑Ready Data Foundations - with Barry Bunin of CDD
Persistent friction between experimental, computational, chemistry, and biology teams continues to slow discovery work, largely due to siloed data and tools that are too difficult for scientists to adopt. In this episode, Barry Bunin, CEO & President at Collaborative Drug Discovery, examines how simplifying data capture and creating a shared source of truth enables faster iteration, clearer model‑
AI That Clinicians Can Trust: Building Reliable Clinical Decision Support with Rhett Alden of Elsevier
Clinicians face a significant trust gap and administrative burden that hinders the effective deployment of AI at the point of care. In this episode, Rhett Alden, CTO at Elsevier, outlines how integrating transparent, peer-reviewed AI assistants directly into clinical workflows can mitigate physician burnout and reduce medical errors. The discussion examines the governance frameworks, data transpar
Automated ECOAs That Reduce Risk and Improve Data Quality with Elan Josielewski & Anthony Mikulaschek of IQVIA
Clinical trials often slow down at the exact points where precision is most critical — manual coding steps, fragmented workflows, and regulatory processes that introduce avoidable risk. In this episode, Elan Josielewski, Senior Director of Patient Centered Solutions at IQVIA, and Tony Mikulaschek, Vice President of eCOA at IQVIA, discuss how connected automation removes these failure points across
AI-Native Discovery in Pharma - with Alister Campbell of Dotmatics
Today's guest is Alister Campbell, Vice President, Global Head of Science and Technology at Dotmatics. Campbell works at the intersection of scientific R&D, data strategy, and applied AI across the drug discovery lifecycle. Alister joins Emerj Client Narrative & Content Strategy Lead Nick Gertsch to discuss how data and AI are shifting pharma R&D from linear, empirical workflows toward tighter, mo
Leading Bold Change and Human-Centered Innovation in Healthcare - with Dr. Imamu Tomlinson of Vituity
Today's guest is Dr. Imamu Tomlinson, CEO of Vituity and President of the Vituity Cares Foundation. Vituity is a physician-owned multispecialty partnership with 6,000+ clinicians across 690 locations. Dr. Tomlinson joins Emerj Editorial Director Marilie Fouché to unpack leadership for driving AI-enabled innovation in healthcare's slow ecosystem. Dr. Tomlinson also shares practical takeaways like c
Reducing Audit Friction and Driving Accountability with AI in Healthcare – with Yasemin Agatan of AdaptHealth
Today's guest is Yasemin Agatan, Senior Vice President of Internal Audit at AdaptHealth, a provider of home medical equipment, supplies, and related services supporting patients living at home. Yasemin brings extensive experience in audit, compliance, and operational risk management within the healthcare sector. She joins Emerj Editorial Director Matthew DeMello to discuss how enterprise leaders c
Driving AI from Pilots to Business Impact in Pharma – with Alyssa Fenoglio of Teva Pharmaceuticals
Today's guest is Alyssa Fenoglio, VP, Global Head of Digital Commercial at Teva Pharmaceuticals. Teva is a global pharmaceutical company delivering both generic and specialty medicines across more than 60 countries. Alyssa joins Emerj CEO and Head of Research Daniel Faggella to discuss the unique challenges of digital transformation in life sciences and how organizations can leverage data and AI t
Driving Audit Workflows in the Era of Agentic AI and IoT for Healthcare - with Yasemin Agatan of Adapt Health
Internal audit sits at the crossroads of regulation, data, and business outcomes—nowhere more than in healthcare and medical devices. Yasemin Agatan, Sr. Vice President of Internal Audit at AdaptHealth, joins Emerj Editorial Director Matthew DeMello to unpack what an "AI-ready" audit looks like in one of the most complex and regulated environments. Yasemin lays out today's top pressures: rapidly s
Dangers of Unchecked AI Development When Politics Meets Machine Learning - with John-Clark Levin of the Yorktown Institute
In this episode of the AI in Healthcare and Life Sciences podcast, host Matthew DeMello speaks with John-Clark Levin, Fellow at the Yorktown Institute and researcher at Kurzweil Research, about the intersection of U.S. politics, AI development, and biosecurity. Levin outlines why the coming years may prove decisive for artificial general intelligence (AGI) and how political volatility under the cu
Bridging the AI Trust Gap in Life Sciences Workflows - with John-Clark Levin of Kurzweil Technologies
Today's guest is John-Clark Levin, Research Lead at Kurzweil Technologies. Kurzweil Technologies, Inc. (KTI) is a research and development company developing and marketing technologies in pattern recognition and artificial intelligence. In this episode, John-Clark unpacks the challenges of deploying AI in healthcare, focusing on reliability, risk tolerance, and the gap between model performance an
Human-Centered AI and the Path to Transformation - with Francesco Tisiot of Aiven
Today's guest is Francesco Tisiot, Field CTO at Aiven. Aiven provides fully managed, open-source data infrastructure on all major clouds. Their platform enables organizations to scale quickly, securely, and cost-effectively — freeing teams to focus on delivering AI applications and business outcomes. Francesco returns to the program to share a pragmatic perspective on AI adoption in highly regulat
Adopting AI Safely and Effectively in Life Sciences - with Francesco Tisiot of Aiven
Today's guest is Francesco Tisiot, Field CTO at Aiven. Aiven provides fully managed, open-source data infrastructure on all major clouds. Their platform enables organizations to scale quickly, securely, and cost-effectively—freeing teams to focus on delivering AI applications and business outcomes. Francesco joins Emerj Senior Editor Matthew DeMello on today's show to discuss what it takes to resp
The Role of AI in Educating the Next Generation of Healthcare Professionals - with Rhett Alden of Elsevier
Today's guest is Rhett Alden, Chief Technology Officer at Elsevier. Elsevier is a global leader in information analytics and academic publishing, providing trusted scientific, technical, and medical content for researchers, clinicians, and professionals. Rhett returns to the podcast to explore how AI is reshaping healthcare education by bridging the gap between emerging technologies and traditiona
Solving AI Transparency Challenges in Healthcare Data - with Rhett Alden of Elsevier
Today's guest is Rhett Alden, Chief Technology Officer at Elsevier. Elsevier is a global leader in information analytics and academic publishing, providing trusted scientific, technical, and medical content for researchers, clinicians, and professionals. Rhett joins us on today's show to discuss how Elsevier is tackling hallucinations in AI frameworks to deliver reliable, peer-reviewed medical and
Breaking Down Regulatory Barriers in Pharma with AI and Automation - with Fred Manby of Iambic Therapeutics
Today's guest is Fred Manby, CTO and Co-founder of Iambic Therapeutics. Iambic uses algorithms to drive a high-throughput experimental platform that specializes in developing new drug discovery techniques. Fred returns to the program to explore the next frontier of AI-driven drug discovery. Building on the previous discussion, this episode delves into the transformative role of automation, data ge
Optimizing Drug Development Pipelines with Machine Learning- with Fred Manby of Iambic Therapeutics
Today's guest is Fred Manby, CTO and Co-founder of Iambic Therapeutics. Iambic uses algorithms to drive a high-throughput experimental platform that specializes in developing new drug discovery techniques. Fred joins us on today's program to discuss the evolving landscape of drug discovery in life sciences. With AI playing an increasingly critical role, the conversation explores the biggest challe
Driving Drug Targeting Efficiencies with LLMs and GenAI - with Ben Coverdale of Patsnap
Today's guest is Ben Coverdale, Global Account Director of Life Sciences at Patsnap. Patsnap is a healthcare technology company that provides IP and R&D teams with enhanced insights to make informed and timely decisions. Using a specialized AI model and the Hiro assistant, the platform boosts productivity and reduces inefficiencies across the innovation lifecycle. Ben returns to the show to dive d
GenAI and LLM Applications in Life Sciences - with Ben Coverdale of Patsnap
Today's guest is Ben Coverdale, Global Account Director of Life Sciences at Patsnap. Patsnap is a healthcare technology company that provides IP and R&D teams with enhanced insights to make informed and timely decisions. Using a specialized AI model and the Hiro assistant, the platform boosts productivity and reduces inefficiencies across the innovation lifecycle. Ben joins us on today's program t
Solving the Go-to-Market Inefficiencies of Life Sciences - with Rajvir Madan of Arcutis Biotherapeutics
Today's guest is Rajvir Madan, Chief Digital and Information Technology Officer at Arcutis Biotherapeutics. Arcutis Biotherapeutics is a biopharmaceutical company that develops therapies for skin-related conditions. Rajvir joins us on today's show to explore the pressing challenges and exciting opportunities within the life sciences industry. From long development timelines to the complexities of
Driving Data Efficiencies in Healthcare - with RJ Kedziora of Estenda Solutions
Today's guest is RJ Kedziora, Co-founder, Partner, Chief Operating Officer, and Chief Technology Officer at Estenda Solutions. Estenda is a healthcare and medical custom software development, data analytics, and consulting company with 20 years of experience in digital health. RJ joins us on today's episode to explore where the industry is seeing use cases for leveraging new AI capabilities to hel
Leveraging Data in Healthcare Organizations - with RJ Kedziora of Estenda Solutions
Today's guest is RJ Kedziora, Co-founder, Partner, and Chief Operating and Technology Officer at Estenda Solutions. Estenda is a healthcare and medical custom software development, data analytics, and consulting company with 20 years of experience in digital health. RJ joins us on today's program to talk about challenges for healthcare leaders in driving the data necessary to take advantage of the
Driving Patient Experiences Through Data Science-Driven Approaches to Infrastructure - with Xiong Liu of Novartis
Today's guest is Xiong Liu, Director of Data Science and AI at Novartis. Xiong joins us on the program today to offer life sciences leaders a framework for driving meaningful data infrastructure advancements at their organizations. Xiong emphasizes the need for robust data quality, ethics considerations, and scalability to ensure practical applications in real-life use cases. Later, he highlights
Winning Buy-In for Life Sciences Manufacturing and Supply Chain Management - with Shreyas Becker of Sanofi
Today's guest is Shreyas Becker, Head of AI & Data Products, Manufacturing & Supply at Sanofi. Shreyas returns to the Emerj podcast platform to talk about best strategies for driving digital transformation in life sciences organizations. Throughout the episode, he offers cogent and tested advice through the lens of manufacturing workflows for the ends of managing up and winning executive buy-in fo
Easing Patient Pain Points Between Healthcare and Insurance Workflows - with Tom Hayes and Gareth Dabbs of IQVIA
Today's guests are Tom Hayes and Gareth Dabbs, Senior Director of Product Strategy & Commercialization and Global Technology Product Strategy Lead at IQVIA, respectively. They return to the p to share two use cases helping to drive quality patient experiences between healthcare and insurance workflows. The first focuses on optimizing omnichannel marketing for compliance. The second use case center
Driving Drug Discovery Efficiencies in Life Sciences with AI - with Anne Phelan of Benevolent
Today's guest is Anne Phelan, Chief Scientific Officer at BenevolentAI. Benevolent is a global leader in applying advanced AI to accelerate pharmaceutical drug discovery, leveraging the latest technologies to uncover new biology, predict novel targets, and develop treatments for some of the world's most complex diseases. Anne joins the program today to give us an insider's view into how her team u
Generative AI for Healthcare - with Dr. Dan Elton of Mass General Brigham
Today's guest is Dr. Dan Elton, a Data Scientist at the Mass General Brigham Data Science Office. He's also a fellow at the Foresight Institute and previously served as a staff scientist at the National Institutes of Health. Dan returns to the Emerj podcast platform following his appearance on the 'AI in Business' podcast to clarify his vision for what he sees as the future of 'preventative care'
Adopting Generative AI in Healthcare Organizations - with Prashant Natajaran of H2O.ai
Today's guest is Prashant Natajaran, Vice President of Strategy and Products at H2O.ai. H2O.ai is a tech company whose platform, the H2O AI Cloud, enables businesses, government entities, nonprofits, and academic institutions to make, operate, and innovate with different AI capabilities like machine learning and AI-enhanced middleware. Prashant joins Emerj CEO and Head of Research Daniel Faggella
Reducing Hallucinations and Streamlining Drug Discovery Workflows with Generative AI - with Asif Hasan of Quantiphi
Today's guest is Asif Hasan, Co-founder of Quantiphi. Quantiphi is an AI-first digital engineering company that designs AI-driven services and platforms for broad applications across industries. In conversation with Emerj CEO and Head of Research Daniel Faggella, Asif discusses reducing hallucinations in healthcare language models and the latest developments in AI's impact on drug discovery for ra
Introducing the 'AI in Healthcare and Life Sciences' Podcast...
Today, we are proud to introduce the latest addition to our burgeoning podcast platform: The 'AI in Healthcare and Life Sciences' podcast! Join the Emerj staff as we converse with Fortune 500 leaders and those at the cutting edge of technological transformations to look at high-level industry trends. Together, we try to anticipate how AI capabilities may be able to solve ensuing business challenge
Recommended
Booked, Blonde & Busy w/ Olivia Ponton
McKinsey on Consumer and Retail
megahired.com
Hard Knocks Podcast
Effective Weight Loss for Moms | High protein, Strength Training, Lose Weight, Meal Planning, Fat Loss, Healthy Habits
The Human-Animal Connection - Pet Life Radio Original
The Daily
World News Tonight with David Muir
English Vocabulary Help
The Joe Rogan Experience
TED Talks Daily
Learn English B1 with Daily News | English Listening Practice
